4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with binospirone mesylate in 1 studies
Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (binospirone mesylate) | Trials (binospirone mesylate) | Recent Studies (post-2010) (binospirone mesylate) |
---|---|---|---|---|---|
42 | 0 | 9 | 32 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gannon, RL | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and binospirone mesylate
Article | Year |
---|---|
Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Circadian Rhythm; Cricetinae; Dioxins; Dose-Response Relationship, Drug; Drug Combinations; Male; Motor Activity; Photoperiod; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Suprachiasmatic Nucleus | 2003 |